<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="MEDLINE" Owner="NLM">        <PMID Version="1">30235721</PMID>        <DateCompleted>            <Year>2018</Year>            <Month>10</Month>            <Day>04</Day>        </DateCompleted>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>14</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Electronic">1536-5964</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>97</Volume>                    <Issue>38</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Sep</Month>                    </PubDate>                </JournalIssue>                <Title>Medicine</Title>                <ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation>            </Journal>            <ArticleTitle>Late complications of totally implantable venous access ports in patients with cancer: Risk factors and related nursing strategies.</ArticleTitle>            <Pagination>                <MedlinePgn>e12427</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000012427</ELocationID>            <Abstract>                <AbstractText>The aim of this study was to assess the incidence rate and the risk factors for late complications associated with use of central totally implanted venous access devices (TIVAPs) in patients with cancer, and to devise nursing strategies to minimize late complications.This retrospective study included 500 patients with TIVAPs from 2012 to 2015. Multivariable logistic regression analysis was performed to assess the effect of sex, age, primary diagnosis, duration of surgery, and the length of hospital stay on the incidence of late complications of TIVAP.The cumulative maintenance period of TIVAP was 159,605 days. Late complications included catheter-related obstruction (n = 14; 2.8%), infection (n = 3; 0.6%), drug extravasation (n = 1; 0.2%), and catheter exposure (n = 1; 0.2%). Multivariate analyses revealed that age, breast cancer, lung cancer, and gastric cancer were risk factors for the late complications associated with TIVAP.There was a low incidence of late complications with TIVAP use. Catheter-related obstruction is the most frequent late complication of TIVAP. Risk factors for TIVAP-associated late complications include age and certain cancers, such as breast cancer, lung cancer, and gastric cancer.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Yu</LastName>                    <ForeName>Xin-Yan</ForeName>                    <Initials>XY</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Abdominal Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Xu</LastName>                    <ForeName>Jia-Lan</ForeName>                    <Initials>JL</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Li</LastName>                    <ForeName>Dan</ForeName>                    <Initials>D</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Jiang</LastName>                    <ForeName>Zi-Fang</ForeName>                    <Initials>ZF</Initials>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>                <PublicationType UI="D064888">Observational Study</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>United States</Country>            <MedlineTA>Medicine (Baltimore)</MedlineTA>            <NlmUniqueID>2985248R</NlmUniqueID>            <ISSNLinking>0025-7974</ISSNLinking>        </MedlineJournalInfo>        <CitationSubset>AIM</CitationSubset>        <CitationSubset>IM</CitationSubset>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Support Care Cancer. 2013 Feb;21(2):505-10</RefSource>                <PMID Version="1">22829323</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Nurs. 2010 Mar;19(5-6):749-65</RefSource>                <PMID Version="1">20500319</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Support Care Cancer. 2016 Feb;24(2):833-841</RefSource>                <PMID Version="1">26201750</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2014 Aug 1;32(22):2351-6</RefSource>                <PMID Version="1">24982458</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Oncol. 2008 Jan;19(1):9-15</RefSource>                <PMID Version="1">17846025</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin J Oncol Nurs. 2007 Aug;11(4):485-8</RefSource>                <PMID Version="1">17723960</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Oncol Nurs. 2015 Apr;19(2):142-7</RefSource>                <PMID Version="1">25465771</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Korean J Thorac Cardiovasc Surg. 2014 Apr;47(2):117-23</RefSource>                <PMID Version="1">24782960</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Support Care Cancer. 2014 Jun;22(6):1705-14</RefSource>                <PMID Version="1">24659216</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mayo Clin Proc. 2006 Sep;81(9):1159-71</RefSource>                <PMID Version="1">16970212</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lancet Infect Dis. 2014 Feb;14(2):146-59</RefSource>                <PMID Version="1">24314751</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Vasc Access. 2004 Oct-Dec;5(4):174-8</RefSource>                <PMID Version="1">16596562</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lancet Oncol. 2002 Nov;3(11):684-92</RefSource>                <PMID Version="1">12424071</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Pediatr Surg. 2006 Sep;41(9):1582-7</RefSource>                <PMID Version="1">16952595</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>World J Surg. 2014 May;38(5):1084-92</RefSource>                <PMID Version="1">24305930</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>World J Gastroenterol. 2009 Oct 7;15(37):4709-14</RefSource>                <PMID Version="1">19787834</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Oncol. 2004 Feb;15(2):296-300</RefSource>                <PMID Version="1">14760125</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Medicine (Baltimore). 2012 Nov;91(6):309-18</RefSource>                <PMID Version="1">23117849</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Arch Surg. 2001 Sep;136(9):1050-3</RefSource>                <PMID Version="1">11529829</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>CA Cancer J Clin. 2008 Nov-Dec;58(6):323-46</RefSource>                <PMID Version="1">18971486</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Oncol Nurs. 2011 Dec;15(5):377-81</RefSource>                <PMID Version="1">21167777</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Pediatr Blood Cancer. 2010 Apr;54(4):546-51</RefSource>                <PMID Version="1">19967773</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Pediatr Hematol Oncol. 2006 Sep;23(6):459-70</RefSource>                <PMID Version="1">16849276</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Infect Control Hosp Epidemiol. 2002 Dec;23(12):759-69</RefSource>                <PMID Version="1">12517020</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nurse Educ Today. 2012 Aug;32(6):709-13</RefSource>                <PMID Version="1">22036273</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin J Oncol Nurs. 2014 Jun;18(3):321-6</RefSource>                <PMID Version="1">24867112</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Surg Oncol. 1998 Jun;24(3):192-9</RefSource>                <PMID Version="1">9630859</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Surg Oncol. 2012 Sep;21(3):207-15</RefSource>                <PMID Version="1">22425356</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Indian J Cancer. 2012 Jan-Mar;49(1):114-8</RefSource>                <PMID Version="1">22842178</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Support Care Cancer. 1998 Jan;6(1):23-30</RefSource>                <PMID Version="1">9458533</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <MeshHeadingList>            <MeshHeading>                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D061807" MajorTopicYN="N">Catheter Obstruction</DescriptorName>                <QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D055499" MajorTopicYN="N">Catheter-Related Infections</DescriptorName>                <QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D002405" MajorTopicYN="N">Catheterization, Central Venous</DescriptorName>                <QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D002408" MajorTopicYN="N">Catheters, Indwelling</DescriptorName>                <QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D002681" MajorTopicYN="N">China</DescriptorName>                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D004358" MajorTopicYN="N">Drug Therapy</DescriptorName>                <QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D005119" MajorTopicYN="N">Extravasation of Diagnostic and Therapeutic Materials</DescriptorName>                <QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName>                <QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName>                <QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D061646" MajorTopicYN="N">Operative Time</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>            </MeshHeading>        </MeshHeadingList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>22</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>22</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>10</Month>                <Day>5</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30235721</ArticleId>            <ArticleId IdType="doi">10.1097/MD.0000000000012427</ArticleId>            <ArticleId IdType="pii">00005792-201809210-00069</ArticleId>            <ArticleId IdType="pmc">PMC6160048</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>